Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Researchers identify heart-specific form of protein that protects against irregular heartbeats

Researchers identify heart-specific form of protein that protects against irregular heartbeats

Research professor of Emory receives 2014 MetLife Foundation Awards for Medical Research

Research professor of Emory receives 2014 MetLife Foundation Awards for Medical Research

MetLife announces recipients of 2014 MetLife Foundation Awards for Medical Research

MetLife announces recipients of 2014 MetLife Foundation Awards for Medical Research

BRF expands study to evaluate whether structured exercise slows progression of AD

BRF expands study to evaluate whether structured exercise slows progression of AD

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Transition Therapeutics begins TT-401 Phase 2 clinical study for treatment of type 2 diabetes

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

Anti-depressants could slow onset of Alzheimer's disease

Anti-depressants could slow onset of Alzheimer's disease

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

Antidepressant stops growth of plaques in mouse model of Alzheimer's disease

Researchers develop new high-tech device for transferring DNA into cells

Researchers develop new high-tech device for transferring DNA into cells

Scientists discover novel protein fragments that may protect against Alzheimer's disease

Scientists discover novel protein fragments that may protect against Alzheimer's disease

Prolong exposure to paint, glue is detrimental for brain

Prolong exposure to paint, glue is detrimental for brain

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

People with longevity gene have improved brain skills

People with longevity gene have improved brain skills

Study of rare childhood neurodegenerative diseases identifies new source of DNA damage

Study of rare childhood neurodegenerative diseases identifies new source of DNA damage

Chinese herbal formula protects against hippocampal neurons death via non-classical estrogen pathway

Chinese herbal formula protects against hippocampal neurons death via non-classical estrogen pathway

Mice study shows specific energy source responsible for performing complex cognitive functions

Mice study shows specific energy source responsible for performing complex cognitive functions

Finding has implications for understanding cognitive decline in degenerative diseases

Finding has implications for understanding cognitive decline in degenerative diseases

RAAV/ABAD-DP-6His generates fusion peptide that protects PC12 cells from oxidative stress injury

RAAV/ABAD-DP-6His generates fusion peptide that protects PC12 cells from oxidative stress injury

Researchers create universal flu vaccine

Researchers create universal flu vaccine

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.